The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Abstract
Drugs of abuse are very powerful reinforcers, and even in conditions of limited access (where the organism is not dependent) these drugs will motivate high rates of operant responding. This presumed hedonic property and the drugs' neuropharmacological specificity provide a means of studying the neuropharmacology and neuroanatomy of brain reward. Three major brain systems appear to be involved in drug reward--dopamine, opioid and GABA. Evidence suggests a midbrain-forebrain-extrapyramidal circuit with its focus in the nucleus accumbens. Data implicating dopamine and opioid systems in indirect sympathomimetic and opiate reward include critical elements in both the nucleus accumbens and ventral tegmental areas. Ethanol reward appears to depend on an interaction with the GABAA receptor complex but may also involve common elements such as dopamine and opioid peptides in this midbrain-forebrain-extrapyramidal circuit. These results suggest that brain reward systems have a multidetermined neuropharmacological basis that may involve some common neuroanatomical elements.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, there is extensive experimental evidence in animal contexts supporting a role for the mesolimbic reward pathway on appetitive and motivational behaviors [306,307].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [307]
In the citing paper
“The meso-limbic dopamine system that projects from the ventral tegmental area (VTA) to the nucleus accumbens has been implicated in the rewarding effects of drugs of abuse”
From Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens–olfactory tubercle complex (2007) · cites this paper as Koob, 1992
Citations
Cites
Handbook of Psychopharmacology
Iversen, L. L., Iversen, S. D., & Snyder, S. H. (1988) · Springer eBooks · doi:10.1007/978-1-4613-0933-8 · Cited by 2,756
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
From motivation to action: Functional interface between the limbic system and the motor system
MOGENSON, G., JONES, D., & YIM, C. (1980) · Progress in Neurobiology · doi:10.1016/0301-0082(80)90018-0 · Cited by 2,331
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Self-citationWise, R. A., & Rompre, P.-P. (1989) · Annual Review of Psychology · doi:10.1146/annurev.ps.40.020189.001203 · Cited by 1,968
An opponent-process theory of motivation. I. Temporal dynamics of affect
Solomon, R. L., & Corbit, J. D. (1974) · Psychological Review · doi:10.1037/h0036128 · Cited by 1,704
Alheid, G. F., & Heimer, L. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90217-5 · Cited by 1,217
Fallon, J. H., & Moore, R. Y. (1978) · The Journal of Comparative Neurology · doi:10.1002/cne.901800310 · Cited by 1,190
Mesocorticolimbic dopaminergic network: functional and regulatory roles
Moal, M. L., & Simon, H. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.1.155 · Cited by 1,108
Di Chiara, G., & Imperato, A. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24578-5 · Cited by 916
Research works printed but not linked: 21
- Dahlström, 1964, Acta Physiol. Scand., 232, 1
- Weiss, F. et al.Ann. NY Acad. Sci. (in press).
- Pfeffer, 1985, Alcohol Drug Res., 6, 37
- Rassnick, S., Pulvirenti, L. and Koob, G. F. Psychopharmacology (in press).
- Samson, 1988, Alcohol. Clin. Exp. Res., 12, 581
- Imperato, 1986, J. Pharmacol. Exp. Ther., 239, 221
- Bodnar, 1990, Crit. Rev. Neurobiol., 6, 39
- West, 1989, Soc. Neurosri. Abstr., 15, 20.8
- Koob, 1984, J. Pharmacol. Exp. Ther., 229, 481
- Goldberg, 1971, J. Pharmacol. Exp. Ther., 176, 464
- Di Chiara, 1988, J. Pharmacol. Exp. Ther., 244, 1067
- Di Chiara, 1988, 85, 5274
- Shippenberg, T. S., Spanagel, R. and Herz, A.Ann. NY Acad. Sci. (in press).
- Givens, 1990, J. Pharmacol. Exp. Ther., 254, 528
- Sepinwall, 1978, Vol. 13, 345
- Koob, G. F. and Britton, K. T. in Pharmacology and Neuropharmacology (Vol. 2) Alcohol and Alcoholisms (Begleiter, H. and Kissin, B., eds), Oxford University Press (in press).
- Frye, 1982, J. Pharmacol. Exp. Ther., 223, 750
- Suzdak, 1986, 83, 4071
- Rassnick, S. et al.Ann. NY Acad. Sci. (in press).
- Deitrich, 1989, Pharmacol. Rev., 41, 489
- Pickens, 1981, J. Pharmacol. Exp. Ther., 216, 205
Cited by
Sorted by citations
Items 801–900 of 1,004
Sprague, J. E., Leifheit, M., Selken, J., Milks, M. M., Kinder, D. H., & Nichols, D. E. (2001) · Synapse · doi:10.1002/syn.10025 · Cited by 49
Loss of Morphine Reward and Dependence in Mice Lacking G Protein–Coupled Receptor Kinase 5
Glück, L., Loktev, A., Moulédous, L., Mollereau, C., Law, P., & Schulz, S. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.021 · Cited by 49
Role of endocannabinoid system in mental diseases
Manzanares, J., Urigüen, L., Rubio, G., & Palomo, T. (2004) · Neurotoxicity Research · doi:10.1007/bf03033223 · Cited by 49
Carr, K. D., Kim, G.-Y., & de Vaca, S. C. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02143-0 · Cited by 49
Blanchard, B. A., Steindorf, S., Wang, S., LeFevre, R., Mankes, R. F., & Glick, S. D. (1993) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1993.tb05651.x · Cited by 49
Maldonado, C., Rodríguez‐Arias, M., Castillo, A., Aguilar, M. A., & Miñarro, J. (2006) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000190685.84984.ec · Cited by 49
Miller, A. D., Forster, G. L., Yeomans, J. S., & Blaha, C. D. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.08.035 · Cited by 49
Betancur, C. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00179-2 · Cited by 49
New drug treatments for alcohol problems: a critical appraisal
Moncrieff, J., & Drummond, C. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb02966.x · Cited by 49
A Behavioral/Systems Approach to the Neuroscience of Drug Addiction
White, F. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03303.2002 · Cited by 49
‘Naltrexone Blocks Endorphins Released when Dancing in Synchrony’
Tarr, B., Launay, J., Benson, C., & Dunbar, R. I. M. (2017) · Adaptive Human Behavior and Physiology · doi:10.1007/s40750-017-0067-y · Cited by 48
Winkler, A., Mahal, B., Kiianmaa, K., Zieglgänsberger, W., & Spanagel, R. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00218-1 · Cited by 48
Olausson, P., Ericson, M., Löf, E., Engel, J. A., & Söderpalm, B. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00903-7 · Cited by 48
Clarke, S., Chen, Z., Hsu, M., Pintar, J. E., Hill, R., & Kitchen, I. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02531-8 · Cited by 48
Ga̧sior, M., Shoaib, M., Yaşar, S., Jaszyna, M., & Goldberg, S. R. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38058-9 · Cited by 48
Wolinsky, T. D., Carr, K. D., Hiller, J. M., & Simon, E. J. (1994) · Brain Research · doi:10.1016/0006-8993(94)91470-2 · Cited by 48
Mach, R. H., Nader, M. A., Ehrenkaufer, R. L., Line, S. W., Smith, C. R., Gage, H. D., & Morton, T. E. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00449-2 · Cited by 48
Müller, C. P., Silva, M. A. D. S., DePalma, G., Tomaz, C. A. B., Carey, R. J., & Huston, J. P. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00042-6 · Cited by 48
The NMDA receptor and cocaine: Evidence that MK-801 can induce behavioral sensitization effects
Carey, R. J., Dai, H., Krost, M., & Huston, J. P. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00074-7 · Cited by 48
Social isolation and social interaction alter regional brain opioid receptor binding in rats
Vanderschuren, L. J. M. J., Stein, E. A., Wiegant, V. M., & van Ree, J. M. (1995) · European Neuropsychopharmacology · doi:10.1016/0924-977x(95)00010-m · Cited by 48
GABA‐ and Glutamate‐evoked Responses in the Rat Ventral Pallidum are Modulated by Dopamine
Johnson, P. I., & Napier, T. C. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01494.x · Cited by 48
The relationships among saccharin consumption, oral ethanol, and IV cocaine self-administration
Gahtan, E. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02148-5 · Cited by 48
Tolliver, B. K., Sganga, M. W., & Sharp, F. R. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00214.x · Cited by 48
Rogers, P. J. (1995) · Nutrition Research Reviews · doi:10.1079/nrr19950015 · Cited by 48
THE ROLE OF NEUROTRANSMITTERS IN ALCOHOL DEPENDENCE ANIMAL RESEARCH
WITTE, P. D. (1996) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a008213 · Cited by 48
Dow-Edwards, D. L., Mayes, L. C., SPEAR, L. P., & Hurd, Y. L. (1999) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(99)00008-2 · Cited by 48
Shin, R. S., Qin, M., Liu, Z., & Ikemoto, S. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1131-x · Cited by 47
Dietary Factors Affect Food Reward and Motivation to Eat
Pandit, R., Mercer, J. G., Overduin, J., la Fleur, S. E., & Adan, R. A. H. (2012) · Obesity Facts · doi:10.1159/000338073 · Cited by 47
Schmidt, A., Denier, N., Magon, S., Radue, E. W., Huber, C. G., Riecher‐Rössler, A., Wiesbeck, G. A., Lang, U. E., Borgwardt, S., & Walter, M. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.28 · Cited by 47
Rapeli, P., Fabritius, C., Kalska, H., & Alho, H. (2009) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-4-6 · Cited by 47
Karimi, S., Azizi, P., Shamsizadeh, A., & Haghparast, A. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.03.022 · Cited by 47
Sahr, A. E., Thielen, R. J., Lumeng, L., Li, T., & McBride, W. J. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000125344.79677.1c · Cited by 47
Opioid effects on activation of neurons in the medial prefrontal cortex
Giacchino, J. L., & Henriksen, S. J. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(98)00053-0 · Cited by 47
Brunelle, C., Barrett, S. P., & Pihl, R. O. (2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.866 · Cited by 47
Alcohol consumption alters dopamine transporter sites in Wistar–Kyoto rat brain
Jiao, X., Paré, W. P., & Tejani‐Butt, S. M. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.009 · Cited by 47
Blockade of δ-Opioid Receptors Prevents Morphine-Induced Place Preference in Mice
Suzuki, T., Yoshiike, M., Mizoguchi, H., Kamei, J., Misawa, M., & Nagase, H. (1994) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.66.131 · Cited by 47
Wei, D., Maisonneuve, I. M., Kuehne, M. E., & Glick, S. D. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00527-7 · Cited by 47
Mengual, E., & Pickel, V. M. (2001) · Synapse · doi:10.1002/syn.10033 · Cited by 47
Zarrindast, M., Fatahi, Z., Rostami, P., & Rezayof, A. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.02.018 · Cited by 47
de Waele, J., & Gianoulakis, C. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90064-7 · Cited by 47
Kim, J. H., & Vezina, P. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37051-x · Cited by 47
rGβ1: A Psychostimulant-Regulated Gene Essential for Establishing Cocaine Sensitization
Wang, X.-B., Funada, M., Imai, Y., Revay, R. S., Ujike, H., Vandenbergh, D. J., & Uhl, G. R. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-15-05993.1997 · Cited by 47
MK-801 Potentiates Ethanol's Effects on Locomotor Activity in Mice
Shen, E. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00389-4 · Cited by 47
Koob, G. F., & Vendruscolo, L. F. (2023) · Current topics in behavioral neurosciences · doi:10.1007/7854_2023_424 · Cited by 46
Self-citationApplication of Human Laboratory Models to Pharmacotherapy Development for Alcohol Dependence
Ray, L. A., Hutchison, K. E., & Tartter, M. A. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791516422 · Cited by 46
Ethanol and cocaine: Environmental place conditioning, stereotypy, and synergism in planarians
Tallarida, C. S., Bires, K., Avershal, J., Tallarida, R. J., Seo, S., & Rawls, S. M. (2014) · Alcohol · doi:10.1016/j.alcohol.2014.07.006 · Cited by 46
The neurocircuitry involved in oxytocin modulation of methamphetamine addiction
Baracz, S. J., & Cornish, J. L. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.08.001 · Cited by 46
Opioidergic Regulation of Emotional Arousal: A Combined PET–fMRI Study
Karjalainen, T., Seppälä, K., Glerean, E., Karlsson, H. K., Lahnakoski, J. M., Nuutila, P., Jääskeläinen, I. P., Hari, R., Sams, M. E., & Nummenmaa, L. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy281 · Cited by 46
Bahk, J. Y., Li, S., Park, M. S., & Kim, M. O. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00243-9 · Cited by 46
COMBINE genetics study: the pharmacogenetics of alcoholism treatment response: genes and mechanisms.
Goldman, D. A., Oroszi, G., O’Malley, S. S., & Anton, R. F. (2005) · Journal of Studies on Alcohol Supplement · doi:10.15288/jsas.2005.s15.56 · Cited by 46
Curran, H. V., Bolton, J., Wanigaratne, S., & Smyth, C. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.9456654.x · Cited by 46
Galaj, E., Manuszak, M., Babic, S., Ananthan, S., & Ranaldi, R. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.09.011 · Cited by 46
Effects of stress on responses to methamphetamine in humans
Gordh, A. S., Nikolayev, L., & de Wit, H. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1536-5 · Cited by 46
Olausson, P., Åkesson, P., Engel, J. A., & Söderpalm, B. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00939-6 · Cited by 46
Nitric oxide mediation of morphine-induced place preference in the nucleus accumbens of rat
Gholami, A., Haeri-Rohani, A., Sahraei, H., & Zarrindast, M. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02038-1 · Cited by 46
Tupala, E., Kuikka, J. T., Hall, H., Bergström, K., Särkioja, T., Räsänen, P. K., Mantere, T., Hiltunen, J. O., Vepsäläinen, J., & Tiihonen, J. (2001) · NeuroImage · doi:10.1006/nimg.2001.0793 · Cited by 46
Zangen, A., Nakash, R., & Yadid, G. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732569.x · Cited by 46
Rönnekleiv, O., & Naylor, B. R. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07330.1995 · Cited by 46
Systems Level Neuroplasticity in Drug AddictionPreprint
Feltenstein, M. W., & See, R. E. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011916 · Cited by 46
Sotomayor, R., Forray, M. I., & Gysling, K. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20537 · Cited by 45
Schmidt‐Mutter, C. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00066-4 · Cited by 45
Zarrindast, M., Massoudi, R., Sepehri, H., & Rezayof, A. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.08.041 · Cited by 45
Müller, C. P. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112672 · Cited by 45
Izzo, E., Orsini, C., Koob, G. F., & Pulvirenti, L. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00472-5 · Cited by 45
Self-citationReappraisal of the association between the DRD2 gene, alcoholism and addiction
Gorwood, P. A. P. M., Batel, P., Gouya, L., Courtois, F., Feingold, J., & Adès, J. (2000) · European Psychiatry · doi:10.1016/s0924-9338(00)00207-8 · Cited by 45
Myers, R. D., & Robinson, D. E. (1999) · Alcohol · doi:10.1016/s0741-8329(99)00015-4 · Cited by 45
Peeyush, K. T., Balakrishnan, S., Sherin, A., Anju, T. R., Jes, P., & Paulose, C. S. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.01.008 · Cited by 45
Plessinger, M. A., & Woods, J. R. (1998) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70360-0 · Cited by 45
Comparative Abuse Liability of Sertraline, Alprazolam, and Dextroamphetamine in Humans
Zawertailo, L. A., Busto, U. E., Kaplan, H. L., & Sellers, E. M. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199504000-00007 · Cited by 45
Rossetio, Z. L., Longu, G., Mercuro, G., & Gessa, G. L. (1993) · Brain Research · doi:10.1016/0006-8993(93)90889-u · Cited by 45
Svingos, A. L., Cheng, P. Y., Clarke, C. L., & Pickel, V. M. (1995) · Brain Research · doi:10.1016/0006-8993(95)00977-x · Cited by 45
Zernig, G., Lewis, J. W., & Woods, J. H. (1997) · Psychopharmacology · doi:10.1007/s002130050185 · Cited by 45
Narita, M., Suzuki, T., Funada, M., Misawa, M., & Nagase, H. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90153-t · Cited by 45
Russig, H., Pezze, M. A., Bahr, N. I., Pryce, C. R., Feldon, J., & Murphy, C. A. (2003) · Behavioural Pharmacology · doi:10.1097/00008877-200302000-00001 · Cited by 45
The etiology of drug abuse: Mapping the paths.
Glantz, M. D., WEINBERG, N. Z., Miner, L. L., & Colliver, J. D. (1999) · American Psychological Association eBooks · doi:10.1037/10341-001 · Cited by 45
Wang, D. V., Viereckel, T., Zell, V., Konradsson‐Geuken, Å., Broker, C. J., Talishinsky, A., Yoo, J. H., Galinato, M. H., Arvidsson, E., Kesner, A. J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.062 · Cited by 44
Thiemann, G., Marzo, V. D., Molleman, A., & Hasenöhrl, R. U. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.01.010 · Cited by 44
Mantsch, J. R., & Goeders, N. E. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00090-8 · Cited by 44
Aricioǧlu-Kartal, F., Kayır, H., & Uzbay, T. I. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00647-7 · Cited by 44
Sahraei, H., Fatemi, S. M., Pashaei-Rad, S., Faghih-Monzavi, Z., Salimi, S. H., & Kamalinegad, M. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2005.08.022 · Cited by 44
Effect of Chronic Ethanol on Enkephalin in the Hypothalamus and Extra‐Hypothalamic Areas
Chang, G., Barson, J. R., Karatayev, O., Chang, S. Y. A., Chen, Y., & LEIBOWITZ, S. F. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01148.x · Cited by 44
Chen, W. J., Chen, C., Huang, J.-L., Hsu, Y. P., Seow, S.-V., Chen, C.-C., & Cheng, A. T. A. (2001) · Psychiatric Genetics · doi:10.1097/00041444-200112000-00002 · Cited by 44
Could a common biochemical mechanism underlie addictions?
Betz, C., Mihalic, D., Pinto, M. E., & Raffa, R. B. (2000) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2000.00260.x · Cited by 44
Cano-Cebrián, M. J., Zornoza, T., Guerri, C., Polache, A., & Granero, L. M. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-002-0674-3 · Cited by 44
Role of Endogenous Neurotensin in the Behavioral and Neuroendocrine Effects of Cocaine
Betancur, C., Cabrera, R., de Kloet, E. R., Pélaprat, D., & Rostène, W. H. (1998) · Neuropsychopharmacology · doi:10.1038/sj.npp.1395212 · Cited by 44
Induction of c-fos in rat brain by acute cocaine and fenfluramine exposure: a comparison study
Torres, G., & RIVIER, C. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)91391-9 · Cited by 44
Effects of the calcium antagonist isradipine on cocaine intravenous self-administration in rats
Martellotta, M. C., Kuzmin, A. V., Muglia, P., Gessa, G. L., & Fratta, W. (1994) · Psychopharmacology · doi:10.1007/bf02245212 · Cited by 44
Wang, X., Jenkins, A., Choi, L., & Murphy, E. H. (1996) · Experimental Brain Research · doi:10.1007/bf00227942 · Cited by 44
Enhanced methamphetamine self-administration in a neurodevelopmental rat model of schizophrenia
Brady, A. M., McCallum, S. E., Glick, S. D., & O’Donnell, P. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1195-7 · Cited by 43
Porrino, L. J., Macey, D. J., Rice, W. N., Freedland, C. S., & Whitlow, C. T. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1676-7 · Cited by 43
Kurling, S., Kankaanpää, A., Ellermaa, S., Karila, T. A., & Seppαlä, T. (2005) · Brain Research · doi:10.1016/j.brainres.2005.02.071 · Cited by 43
Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridine
Maisonneuve, I. M., & Glick, S. D. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00560-9 · Cited by 43
Schad, C. A., Justice, J. B., & Holtzman, S. G. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.932 · Cited by 43
Mizuo, K., Narita, M., Miyagawa, K., Narita, M., Okuno, E., & Suzuki, T. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.11.027 · Cited by 43
Do antidepressants affect motivation in conditioned place preference?
Subhan, F., Deslandes, P. N., Pache, D. M., & Sewell, R. D. E. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00771-8 · Cited by 43
Erdtmann-Vourliotis, M., Mayer, P. E., Riechert, U., Grecksch, G., & Höllt, V. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00197-1 · Cited by 43
Kindlundh, A. M. S., Lindblom, J., & Nyberg, F. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02843-9 · Cited by 43
Narita, M., Mizuo, K., Shibasaki, M., Narita, M., & Suzuki, T. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00515-2 · Cited by 43
Carr, K. D., & Kutchukhidze, N. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02018-7 · Cited by 43
Whatley, V. J., Johnson, T. E., & Erwin, V. G. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04287.x · Cited by 43
Metadata
- Authors
- Koob, G. F.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Koob, George F.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 1992-01
- Volume
- 13
- Issue
- 5
- Pages
- 177-184
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2001865657
- Cited by
- 2,070
- References
- 73
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 12 · 2023: 16 · 2022: 17 · 2021: 28 · 2020: 30 · 2019: 28 · 2018: 46 · 2017: 42 · 2016: 43 · 2015: 37 · 2014: 58 · 2013: 53 · 2012: 53
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Pharmacological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (AA-08459)
- National Institute on Drug Abuse (DA04043, DA04398, R01DA004398, R01DA004043)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- drugs of abuse, brain reward system, dopamine, opioid system, GABA, nucleus accumbens, ventral tegmental area, ethanol reward, opioid reward, operant responding
- MeSH terms
- Animals, Brain, Humans, Reward, Illicit Drugs, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review